Education
About Us
Working with TipRanks
Follow Us
Bioventus (BVS)
NASDAQ:BVS
Total Valuation
Bioventus has a market cap or net worth of $620.31M. The enterprise value is $1.04B.
Market Cap$620.31M
Enterprise Value$1.04B
Share Statistics
Bioventus has 66.16M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding66.16M
Owened by Insiders32.14%
Owened by Instutions0.18%
Financial Efficiency
Bioventus’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-33.21%
Return on Assets (ROA)-6.75%
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00%
Revenue Per Employee$616,430.108
Profits Per Employee-$36,066.667
Employee Count930
Asset Turnover0.79
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bioventus is -13.97. Bioventus’s PEG ratio is 0.20.
PE Ratio-13.97
PS Ratio1.20
PB Ratio4.64
Price to Fair Value4.64
Price to FCF17.69
Price to Operating Cash Flow17.69
PEG Ratio0.20
Income Statement
In the last 12 months, Bioventus had revenue of $573.28M and earned -$33.54M in profits. Earnings per share was -$0.51.
Revenue$573.28M
Gross Profit$384.41M
Operating Income$23.89M
Pretax Income-$49.13M
Net Income-$33.54M
EBITDA28.94M
Earnings Per Share (EPS)-0.51
Cash Flow
In the last 12 months, operating cash flow was $37.62M and capital expenditures -$1.72M, giving a free cash flow of $35.90M billion.
Operating Cash Flow$37.62M
Free Cash Flow$35.90M
Free Cash Flow per Share$0.54
Dividends & Yields
Bioventus pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield5.65%
Earnings Yield-7.16%
Stock Price Statistics
Beta1.22
52-Week Price Change63.68%
50-Day Moving Average9.71
200-Day Moving Average10.01
Relative Strength Index (RSI)45.59
Average Volume (3m)399.98K
Important Dates
Bioventus upcoming earnings date is May 13, 2025, After Close.
Last Earnings DateMar 11, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend Date―
Financial Position
Bioventus as a current ratio of 1.31, with Debt / Equity ratio of 0.18
Current Ratio1.31
Quick Ratio0.87
Debt to Market Cap0.04
Net Debt to EBITDA0.29
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bioventus has paid -$5.29M in taxes.
Income Tax-$5.29M
Effective Tax Rate100.00%
Enterprise Valuation
Bioventus EV to EBITDA ratio is -13.56, with an EV/FCF ratio of 17.32.
EV to Sales1.17
EV to EBITDA-13.56
EV to Free Cash Flow17.32
EV to Operating Cash Flow17.32
Balance Sheet
Bioventus has $41.58M in cash and marketable securities with $27.34M in debt, giving a net cash position of -$14.24M billion.
Cash & Marketable Securities$41.58M
Total Debt$27.34M
Net Cash-$14.24M
Net Cash Per Share-$0.22
Tangible Book Value Per Share-$3.47
Margins
Gross margin is 100.00%, with operating margin of 0.00%, and net profit margin of -8.57%.
Gross Margin100.00%
Operating Margin0.00%
Pretax Margin-8.57%
Net Profit Margin-8.57%
EBITDA Margin-8.64%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bioventus is $16.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$16.00
Price Target Upside111.36%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast11.89%
EPS Growth Forecast79.18%